Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors
Thursday, May 30, 2024Biohaven Ltd a global clinicalstage biopharmaceutical company focused on the discovery development and commercialization of lifechanging therapies to treat
Celltrion Receives European Commission Approval for Omlyclo ® (CT-P39), the First and Only Omalizumab Biosimilar Approved in Europe
Wednesday, May 29, 2024Celltrion today announced that the European Commission has approved Omlyclo an omalizumab biosimilar drug referring to Xolair Omlyclo is approved
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Wednesday, May 29, 2024BioThera Solutions a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars and global specialty generic and consumer healthcare medicines company
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
Wednesday, May 29, 2024Prothena Corporation plc a latestage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Tuesday, May 28, 2024Shanghai Henlius Biotech Inc and Organon today announced that the European Medicines Agency has validated the marketing authorization applications for HLX
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
Monday, May 27, 2024Sobi North America the North American affiliate of Swedish Orphan Biovitrum AB today announced that the US Food and Drug Administration has granted Fast
AbbVie Completes Acquisition of Landos Biopharma
Friday, May 24, 2024AbbVie announced today that it has completed its acquisition of Landos Biopharma Inc With the completion of the acquisition Landos is now part of AbbVie Landos lead investigational asset is NX a firstinclass oral NLRX agonist which is currently in Ph...
Theriva™ Biologics Announces US FDA Fast Track Designation for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
Friday, May 24, 2024Theriva Biologics a diversified clinicalstage company developing therapies designed to treat cancer and related diseases in areas of high deprivation today announced that the US Food and Drug Administration
Sandoz Receives European Commission Approval for Wyost® and Jubbonti®, the First and Only Biosimilars of Denosumab in Europe
Thursday, May 23, 2024Sandoz the global leader in generic and biosimilar medicines today announced that the European Commission has granted marketing authorization for Wyost
Bempedoic Acid and Its Fixed-dose Association With Ezetimibe Also Approved in Europe to Lower Cholesterol and Reduce Cardiovascular Risk
Thursday, May 23, 2024The European Commission has approved the extension of the indications of both bempedoic acid and the fixeddose combination of bempedoic acid and ezetimibe
